Prostatype Genomics AB

NEW
OSTO:PROGEN (Sweden)   Ordinary Shares
kr 0.16 +0.0040 (+2.56%) Jul 31
At Loss
P/B:
0.93
Market Cap:
kr 24.89M ($ 2.61M)
Enterprise V:
kr 21.12M ($ 2.22M)
Volume:
1.14M
Avg Vol (2M):
1.13M
Trade In:
Volume:
1.14M
At Loss
Avg Vol (2M):
1.13M

Prostatype Genomics AB (OSTO:PROGEN) Dividend

Prostatype Genomics AB (OSTO:PROGEN) does not currently pay a regular dividend. Over the past 3 years it has returned capital to shareholders via buybacks at a rate of -421%. View its historical dividend record below and compare with dividend-paying peers.

Frequently Asked Questions: OSTO:PROGEN Dividend

Does Prostatype Genomics AB (OSTO:PROGEN) pay a dividend?

Prostatype Genomics AB (OSTO:PROGEN) does not currently pay a regular dividend. Review the historical record above for any past dividend payments or capital return policies.

Why doesn't Prostatype Genomics AB pay a dividend?

Companies typically forgo dividends to reinvest earnings into growth, R&D, acquisitions, or share buybacks. Prostatype Genomics AB has returned capital to shareholders via buybacks at a rate of -421% over the past 3 years.

What are dividend-paying alternatives to Prostatype Genomics AB?

For dividend-paying alternatives in Prostatype Genomics AB's sector, view dividend stocks by industry on GuruFocus's dividend stock screener.